Consultation

We're the pathology subject matter experts, here to help you navigate the complex relationships between clinical and microscopic findings.

Get in Touch Research Areas

We help fill the vacant seat on your drug development team

Study Design and Endpoints

Model selection

Model development by checkpoint H&E review

Collaboration for a catered approach with novel solutions

Data Integration/ Interpretation

Holistic integration of clinical (in-vivo) findings, clinical pathology, and macroscopic findings with microscopic findings

Resource for study reporting and regulatory filings

Recommendations on IHC/ISH selection based on bulk RNAseq, western blot/ELISA, transcriptomics, or other RNA/DNA/protein data

Connection with Subject Matter Experts

In-Vivo CROs

Toxicologists

MD Pathologists

Molecular Biology Partners

How Do I Start?

DTR labs is now local to Boston and are excited to extend some additional services.

Schedule a Call

Speak With Us

Speak with your assigned pathologist and team of scientists

Make a Plan

Together, we'll create a plan for your samples!

Additional Services

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Digital Pathology

Leverage our digital pathology services for tailored solutions, including custom algorithms and high-throughput screening with advanced image analysis.

Image Analysis Capabilities

Pathology

Experienced pathologists support your preclinical program with a thorough microscopic evaluation, precise data interpretation, and detailed reporting to drive your research forward.

Advanced Staining

Gain deeper insights with our IHC/ISH staining services, providing critical support for assessing efficacy and model development endpoints.

Imaging

You'll have access to your brightfield or fluorescent images on our web-based hosting platform. Take snapshots, compare images, or share with colleagues.

Histology

We offer a comprehensive range of staining options to produce high-quality slides, ensuring precise and reliable interpretation for your research needs.

FAQs

Will you help me determine which stains or endpoints are necessary and worth pursuing?

Yes! While you may come to us with specific interests in mind, we may offer suggestions for staining paradigms that have worked well in the past or will be more optimal for your endpoints of interest. We'll also advise on which pathology or image analysis methods will provide you with the most meaningful datasets. We offer staining/analytical pilots to help foster understanding of our process and can work with you to identify what will be most informative for your study goals.

What industries do you serve?

We serve small-large pharma/biotech, start-ups, and academia.

Should we set up a confidentiality agreement before the consultation?

Setting up a CDA prior to the consultation allows both parties to share critical information to guide the discussion. However, we can absolutely chat without an agreement in place and move forward when you’re ready.

Do you offer a la carte services?

Yes! We can accept materials at any stage after fixation and can provide any deliverable from our lab’s service areas: blocks, histochemically or immunohistochemically-stained slides, whole slide images, manual or digital pathology data and reports.

Where are your labs located?

We have sites in both Boston, MA and Dallas, TX.

What information can I provide to DTR during our consultation?

Big Picture: What is the goal of your research? What diseases/therapeutic areas are you focusing on? What is your drug platform? What level of involvement do you need from us: reliable service provider to invested collaborator? Study Timeline: What stage is the study at, i.e. are you planning the in-life? Has it already begun? Are materials collected? Deadlines: Do you have a specific deadline to meet for a high-level meeting/grant submission? Strategy: Is a stepwise approach helpful? Do you have references for endpoints? Are there specific endpoints that are critical for your regulatory submission? Do you have specific features that need prioritization?

When should I contact DTR Labs?

We love to get to know you and your projects well before histopathology is being considered. This allows us to offer advice on model selection and lend insight into endpoint considerations. We can also connect you with any one of our partnering in-life CROs and consultants so you can start off on the right foot.

Ready to chat?

Schedule a call with our team of scientists and your designated pathologist to get started!